BioInsights - Addressing HEK293 cell lineage and AAV diversity with media panel

Addressing HEK293 cell lineage and AAV diversity with media panel

Cell & Gene Therapy Insights 2021; 7(9), 933

10.18609/cgti.2021.124

Published: 29 September 2021
FastFacts
Jennifer Schieber

Watch the video or read the poster to learn:

  • Understanding diversity in HEK cell lineages
  • Significance of media screening in AAV process development
  • Factors driving performance beyond titer
  • Importance of adaptation strategy in media screening

Jennifer Schieber is a senior R&D scientist for Thermo Fisher Scientific. She’s been a part of Thermo Fisher Scientific since 2020 and joined to enable product development to ensure customers have the necessary tools to help create a healthier world. She earned a PhD in pharmacology from The State University of New York at Buffalo, focused on the neuronal basis of opiate addiction, utilizing preclinical models and viral-mediated gene therapy to target changes in the brain. Her current focus is on development of products and solutions to enhance therapeutic potential of gene therapy manufacturing.




We hope you enjoyed this FastFacts video. You can also view the summary PDF here.

 

Authorship & Conflict of Interest

Contributions:  All  named  authors  take  responsibility  for  the  integrity  of  the  work  as a  whole,  and  have given their approval for this version to be published.Acknowledgements: None

Disclosure and potential conflicts of interest: The author is an employee of Thermo Fisher Scientific.  The author has no other conflicts of interest to disclose. 

Funding declaration: The authors received no financial support for the research, authorship and/or publication of this article.

Article & copyright information

Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which  allows anyone  to  copy,  distribute,  and  transmit  the  article  provided  it  is  properly  attributed  in  the  manner specified below. No commercial use without permission.

Attribution: Copyright © 2021 Thermo Fisher Scientific. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.

Article source: From a Fast Facts video recorded on: Aug 11 2021; Publication date: Sep 29 2021.